Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Chloé, Couzin"'
Autor:
Filippo Massa, PhD, Marion Cremoni, MD, Alexandre Gérard, MD, Hanen Grabsi, Lory Rogier, Mathilde Blois, MD, Chloé Couzin, MD, Nadia Ben Hassen, Matthieu Rouleau, PhD, Susana Barbosa, PhD, Emanuela Martinuzzi, PhD, Julien Fayada, Ghislaine Bernard, MD-PhD, Guillaume Favre, MD-PhD, Paul Hofman, MD-PhD, Vincent L.M. Esnault, MD-PhD, Cecil Czerkinsky, MD-PhD, Barbara Seitz-Polski, MD-PhD, Nicolas Glaichenhaus, PhD, Antoine Sicard, MD-PhD
Publikováno v:
EBioMedicine, Vol 73, Iss , Pp 103679- (2021)
Background: The immunogenicity of a two-dose mRNA COVID-19 vaccine regimen is low in kidney transplant (KT) recipients. Here, we provide a thorough assessment of the immunogenicity of a three-dose COVID-19 vaccine regimen in this population. Methods:
Externí odkaz:
https://doaj.org/article/6aec33f0dd6e4ddba8069d07e0e047f1
Autor:
Marianne Delville, Fabien Touzot, Chloé Couzin, Isabelle Hmitou, Lounes Djerroudi, Amani Ouedrani, François Lefrère, Caroline Tuchman-Durand, Chloé Mollet, Jean-Roch Fabreguettes, Nicolas Ferry, Laurent Laganier, Alessandra Magnani, Elisa Magrin, Valérie Jolaine, Asier Saez-Cirion, Orit Wolstein, Geoffrey Symonds, Pierre Frange, Hélène Moins-Teisserenc, Marie-Laure Chaix-Baudier, Antoine Toubert, Jérôme Larghero, Nathalie Parquet, Anne C. Brignier, Françoise Barré-Sinoussi, Eric Oksenhendler, Marina Cavazzana
Publikováno v:
Molecular Therapy: Methods & Clinical Development, Vol 13, Iss , Pp 303-309 (2019)
Although the risk of developing lymphoma has decreased in the highly active antiretroviral therapy era, this cancer remains the major cause of mortality in HIV-infected patients. Autologous hematopoietic stem cell transplantation (ASCT) outcome does
Externí odkaz:
https://doaj.org/article/5d96b92dcd0d438695424b699fd1dfd0
Autor:
Alessandra Magnani, Corinne Pondarré, Naïm Bouazza, Jeremy Magalon, Annarita Miccio, Emmanuelle Six, Cecile Roudaut, Cécile Arnaud, Annie Kamdem, Fabien Touzot, Aurélie Gabrion, Elisa Magrin, Chloé Couzin, Mathieu Fusaro, Isabelle André, Jean-Paul Vernant, Eliane Gluckman, Françoise Bernaudin, Dominique Bories, Marina Cavazzana
Publikováno v:
Haematologica, Vol 105, Iss 5 (2020)
Although studies of mixed chimerism following hematopoietic stem cell transplantation in patients with sickle cell disease (SCD) may provide insights into the engraftment needed to correct the disease and into immunological reconstitution, an extensi
Externí odkaz:
https://doaj.org/article/5e2e03a1b4074479877aa42ad2bc5785
Autor:
Chantal Lagresle-Peyrou, François Lefrère, Elisa Magrin, Jean-Antoine Ribeil, Oriana Romano, Leslie Weber, Alessandra Magnani, Hanem Sadek, Clémence Plantier, Aurélie Gabrion, Brigitte Ternaux, Tristan Félix, Chloé Couzin, Aurélie Stanislas, Jean-Marc Tréluyer, Lionel Lamhaut, Laure Joseph, Marianne Delville, Annarita Miccio, Isabelle André-Schmutz, Marina Cavazzana
Publikováno v:
Haematologica, Vol 103, Iss 5 (2018)
Sickle cell disease is characterized by chronic anemia and vaso-occlusive crises, which eventually lead to multi-organ damage and premature death. Hematopoietic stem cell transplantation is the only curative treatment but it is limited by toxicity an
Externí odkaz:
https://doaj.org/article/38e6828b68394087a1a5f54437c70e29
Autor:
Steicy Sobrino, Alessandra Magnani, Michaela Semeraro, Loredana Martignetti, Akira Cortal, Adeline Denis, Chloé Couzin, Capucine Picard, Jacinta Bustamante, Elisa Magrin, Laure Joseph, Cécile Roudaut, Aurélie Gabrion, Tayebeh Soheili, Corinne Cordier, Olivier Lortholary, François Lefrere, Frédéric Rieux-Laucat, Jean-Laurent Casanova, Sylvain Bodard, Nathalie Boddaert, Adrian J. Thrasher, Fabien Touzot, Sophie Taque, Felipe Suarez, Ambroise Marcais, Agathe Guilloux, Chantal Lagresle-Peyrou, Anne Galy, Antonio Rausell, Stephane Blanche, Marina Cavazzana, Emmanuelle Six
Publikováno v:
Cell Reports Medicine. 4:100919
Autor:
Cecil Czerkinsky, Antoine Sicard, Matthieu Rouleau, Alexandre Gérard, Ghislaine Bernard, Paul Hofman, Lory Rogier, Chloé Couzin, Emanuela Martinuzzi, Nadia Ben Hassen, Julien Fayada, Marion Cremoni, Nicolas Glaichenhaus, Susana Barbosa, Filippo Massa, Guillaume Favre, Mathilde Blois, V. Esnault, Barbara Seitz-Polski, Hanen Grabsi
Publikováno v:
EBioMedicine, Vol 73, Iss, Pp 103679-(2021)
EBioMedicine
EBioMedicine
Background: The immunogenicity of a two-dose mRNA COVID-19 vaccine regimen is low in kidney transplant (KT) recipients. Here, we provide a thorough assessment of the immunogenicity of a three-dose COVID-19 vaccine regimen in this population. Methods:
Autor:
Isabelle André, Kuiying Ma, Laura E. Simons, Chloé Couzin, Jean-Sébastien Diana, Ranjita Devi Moirangthem, Elisa Magrin, Alessandra Magnani, Marina Cavazzana
Publikováno v:
Bone Marrow Transplantation. 54:749-755
Prolonged T-cell immunodeficiency following HLA- incompatible hematopoietic stem cell transplantation (HSCT) represents a major obstacle hampering the more widespread use of this approach. Strategies to fasten T-cell reconstitution in this setting ar
Autor:
Isabelle André, Laura Simons, Kuiying Ma, Ranjita Devi Moirangthem, Jean-Sébastien Diana, Elisa Magrin, Chloé Couzin, Alessandra Magnani, Chantal Lagresle-Peyrou, Marina Cavazzana
Publikováno v:
Bone Marrow Transplantation. 57:851-851
Autor:
Jean-Herlé Raphalen, Chloé Couzin, Horiya Amrane, Jean-Sébastien Diana, David Sibon, Alessandra Magnani, Marianne Delville, Ambroise Marcais, Elisa Magrin, Sandra Manceau, Emilie Dupont, Felipe Suarez, Marina Cavazzana, Laure Joseph, François Lefrère
Publikováno v:
Journal of clinical apheresisREFERENCES. 36(1)
Background Autologous and allogeneic hematopoietic stem cell transplantation of cytokine-mobilized peripheral blood stem cells (PBSCs) is increasingly used to treat patients with hematologic disorders. Different types of vascular access have been exp
Autor:
Hélène Boucher, Lionel Faivre, Audrey Cras, Valérie Vanneaux, Olivier Sibony, Thomas Domet, Jérôme Larghero, Chloé Couzin, André Desproges, Marina Bechard
Publikováno v:
Transfusion. 58:520-531
After 30 years of hematopoietic stem cell use for various indications, umbilical cord blood is considered as an established source of cells with marrow and postmobilization peripheral blood. The limited number of cells still remains a problematic ele